Pregabalin Capsule
Product Images NDC 70518-4272

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 70518-4272). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a description for Pregabalin 25 mg capsules. The prescription medication is in a bottle containing 30 capsules. The manufacturer is Camber Pharma, Inc located in Piscataway, NJ. The NDC number is 70518-4272-00, with a source NDC of 31722-0610-20. The medication should be kept out of the reach of children and stored at temperatures between 20-25°C (58-77°F). The directions for use can be found in the package insert. The medication has been repackaged by RemedyRepack Inc. in Indiana, PA.*

FDA Label Image

Pregabalinfigure1 (Pregabalinfigure1)

FDA Label Image

Pregabalinfigure10 (Pregabalinfigure10)

FDA Label Image

Pregabalinfigure11 (Pregabalinfigure11)

FDA Label Image

Pregabalinfigure12 (Pregabalinfigure12)

FDA Label Image

Pregabalinfigure2 (Pregabalinfigure2)

FDA Label Image

Pregabalinfigure3 (Pregabalinfigure3)

FDA Label Image

Pregabalinfigure4 (Pregabalinfigure4)

This text provides information on the percentage of patients improved with different dosages of Pregabalin and Placebo. The data shows the improvement in pain from baseline for each treatment group.*

FDA Label Image

Pregabalinfigure5 (Pregabalinfigure5)

FDA Label Image

Pregabalinfigure6 (Pregabalinfigure6)

FDA Label Image

Pregabalinfigure7 (Pregabalinfigure7)

FDA Label Image

Pregabalinfigure8 (Pregabalinfigure8)

This text provides information on responder rates for different dosages in a study. The responder rates for each dosing group are 22.6%, 29.1%, and 40.6%. Two dosages are mentioned: 2.5 mg/kg/day and 10 mg/kg/day, with participant counts provided for each dosage group.*

FDA Label Image

Pregabalinfigure9 (Pregabalinfigure9)

This information provided shows the percent of patients improved based on different dosages of Pregabalin and a placebo. The data includes the daily doses of Pregabalin (600mg, 450mg, and 300mg) and a placebo with the corresponding percentage improvement in pain from baseline.*

FDA Label Image

Pregabalinstructure (Pregabalinstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.